House OKs DEA control of gamma butyrolactone (GBL)
On January 31, the US House of Representatives passed the Hillory J.
Farias and Samantha Reid Date-Rape Drug Prohibition Act, which allows
the Drug Enforcement Administration control over the dietary supplement
GBL. The legislation places GBL in a regulatory category similar to
a prescription drug, making it easier to restrict its distribution.
The supplement has been widely available over the Internet, despite
FDA requests last year that distribution cease.
The Arizona Republic, February 2, 2000.
|
